The Hard Sell copertina

The Hard Sell

Crime and Punishment at an Opioid Startup

Anteprima
Offerte di stagione
0,99 €/mese per i primi 3 mesi
Acquista a 10,68 € e iscriviti ora
L'offerta termina il 28 dicembre 2026.
Risparmia più del 90% nei primi 3 mesi.
Ascolta quanto vuoi, scegliendo tra migliaia di audiolibri e serie originali inclusi.
Scarica il tuo audiolibro e ascolta offline, senza interruzioni
Rinnovo automatico a 9,99 €/mese dopo 3 mesi. Disdici mensilmente. L'offerta termina il 28 dicembre 2026.

The Hard Sell

Di: Evan Hughes
Letto da: Mike Chamberlain
Acquista a 10,68 € e iscriviti ora

Rinnovo automatico a 9,99 €/mese dopo 3 mesi. Puoi disdire mensilmente. L'offerta termina il 28 dicembre 2026.

Acquista ora a 13,87 €

Acquista ora a 13,87 €

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A proposito di questo titolo

Soon to be the major motion picture Pain Hustlers starring Emily Blunt and Chris Evans streaming on Netflix

‘A pacey crime caper set against the backdrop of the opioid crisis . . . When I tell you that reading The Hard Sell is like watching a Scorsese film, you will assume I am exaggerating. Pick it up and tell me I’m wrong.' - Patrick Radden Keefe, The New York Times


In the early 2000s, John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. A boom time for painkillers, he had developed a novel formulation of fentanyl, the most potent opioid on the market.

Kapoor, a brilliant scientist with relentless business instincts, was eager to make the most of his innovation. But there was a problem: the drug was approved only for cancer patients in dire condition. So he recruited an avaricious team, who employed a variety of deceptive techniques, from falsifying patient records to deceiving insurance companies. Insys became a Wall Street sensation. That is, until insiders reached their breaking point and blew the whistle, sparking a sprawling investigation in the government’s fight to hold the drug industry accountable in the spread of addictive opioids.

With colourful characters and true suspense, The Hard Sell lays bare the pharma playbook. Evan Hughes offers a bracing look not just at Insys, but at how opioids are sold at the point they first enter the national bloodstream – in the doctor’s office . . .

Crimini reali Legge Parole, lingua e grammatica
adbl_web_anon_alc_button_suppression_t1

Recensioni della critica

'This is that rare story of the opioid crisis in which the bad guys face a genuine reckoning. I couldn't turn the pages fast enough. A tour de force.' (Patrick Radden Keefe)
'A fast-paced and maddening account . . . What’s most surprising and powerful about The Hard Sell is not one company’s criminality . . . as much as how institutionalized these practices were across the modern drug industry.'
A pacey crime caper set against the backdrop of the opioid crisis . . . When I tell you that reading “The Hard Sell” is like watching a Scorsese film, you will assume I am exaggerating. Pick it up and tell me I’m wrong
Vivid . . . [An] insightful account of how a company that went public in the most successful IPO of 2013 soon ended up a poster child for corporate greed
Does the world really need another book about the opioid crisis? . . . The Hard Sell by Evan Hughes proves a worthy addition to the collection.
A richly reported, mesmerizing tale, and a devastating indictment of our broken pharmaceutical industry. Everyone should read this book. (Sheelah Kolhatkar, author of Black Edge)
When you’re running a pharma startup, how does the obvious wrong thing to do become the thing you do anyway? The Hard Sell, fascinating in the fashion of a slow-moving train wreck, is a study of corruption (Ted Conover, author of Newjack)
Ancora nessuna recensione